LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 104 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $150,132 | -55.1% | 137,735 | 0.0% | 0.00% | – |
| Q2 2023 | $334,697 | 0.0% | 137,735 | 0.0% | 0.00% | – |
| Q1 2023 | $334,697 | +47.2% | 137,735 | +15.7% | 0.00% | – |
| Q4 2022 | $227,378 | -99.9% | 119,046 | 0.0% | 0.00% | – |
| Q3 2022 | $285,711,000 | -12.7% | 119,046 | -32.3% | 0.00% | – |
| Q2 2022 | $327,267,000 | +86.7% | 175,950 | +109.8% | 0.00% | – |
| Q1 2022 | $175,297,000 | -47.0% | 83,874 | 0.0% | 0.00% | – |
| Q4 2021 | $330,464,000 | -18.1% | 83,874 | 0.0% | 0.00% | – |
| Q3 2021 | $403,435,000 | +15.1% | 83,874 | +9.8% | 0.00% | – |
| Q2 2021 | $350,561,000 | +271.9% | 76,375 | +58.0% | 0.00% | – |
| Q1 2020 | $94,265,000 | -98.0% | 48,341 | -95.7% | 0.00% | -100.0% |
| Q4 2019 | $4,613,340,000 | +36.9% | 1,111,648 | -0.7% | 0.00% | +50.0% |
| Q3 2019 | $3,368,792,000 | -51.9% | 1,119,200 | +0.4% | 0.00% | -60.0% |
| Q2 2019 | $7,010,400,000 | +13.1% | 1,114,531 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $6,196,793,000 | -68.3% | 1,114,531 | -62.1% | 0.01% | -70.6% |
| Q4 2018 | $19,537,688,000 | -51.9% | 2,942,423 | -22.6% | 0.02% | -43.3% |
| Q3 2018 | $40,588,977,000 | -14.9% | 3,804,028 | -4.3% | 0.03% | -18.9% |
| Q2 2018 | $47,698,752,000 | +38.7% | 3,974,896 | -1.0% | 0.04% | +37.0% |
| Q1 2018 | $34,393,750,000 | -16.3% | 4,013,273 | -3.5% | 0.03% | -22.9% |
| Q4 2017 | $41,105,465,000 | -6.5% | 4,160,472 | +16.3% | 0.04% | -12.5% |
| Q3 2017 | $43,968,088,000 | -29.9% | 3,577,550 | -6.2% | 0.04% | -34.4% |
| Q2 2017 | $62,732,109,000 | +7.0% | 3,813,502 | -6.7% | 0.06% | +1.7% |
| Q1 2017 | $58,642,269,000 | +102804.6% | 4,089,419 | -0.8% | 0.06% | -6.2% |
| Q4 2016 | $56,987,000 | -34.2% | 4,120,509 | -14.0% | 0.06% | -31.2% |
| Q3 2016 | $86,573,000 | -8.2% | 4,790,981 | -27.1% | 0.09% | -13.1% |
| Q2 2016 | $94,289,000 | +9.3% | 6,570,712 | -9.0% | 0.11% | +7.0% |
| Q1 2016 | $86,299,000 | -23.3% | 7,221,718 | -14.6% | 0.10% | -21.9% |
| Q4 2015 | $112,504,000 | +24.9% | 8,452,515 | +0.8% | 0.13% | +29.3% |
| Q3 2015 | $90,099,000 | +72.9% | 8,389,120 | +29.6% | 0.10% | +98.0% |
| Q2 2015 | $52,113,000 | – | 6,473,674 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |